Thursday 26 October | 08.30-10.00

 
HRS-VA Joint Session
CONTROVERSIES IN STROKE REDUCTION AMONG AF PATIENTS
Chairs: T.F. Deering / Atlanta, USA –
A.M. Russo / Camden, USA

 
• Should patients with AF and a CHA2DS2- VASc of 0-1 ever be anticoagulated? Consideration of other risk factors
M. Rienstra / Groningen, The Netherlands
• Atrial arrhythmias detected by implantable devices: when should anticoagulation be initiated?
M.P. Turakhia / Stanford, USA
• Which patients with cryptogenic stroke should be anticoagulated?
J. Brachmann / Coburg, Germany
• Choosing between left atrial appendage closure and oral anticoagulation
D. Lakkireddy / Kansas City, USA